TerminatedNot Applicable

OCS Liver DCD Trial

Stopped: Enrollment in Liver DCD was stopped as a result of the FDA approval for the OCS Liver System and follow-up ended on 12/16/2024 based on adequate patient follow-up.

United States9 participantsStarted 2020-07-24

Plain-language summary

Evaluate the safety and effectiveness of the OCS Liver System to preserve, optimize the condition, and assess levers from DCD donors.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Registered primary liver transplant candidate * Age ≥ 18 years * Obtained informed consent Exclusion Criteria: * Acute, fulminant liver failure * Prior solid organ or bone marrow transplant * Ventilator dependent on day of transplant/donor organ offer

What they're measuring

Liver Graft Survival Through 6 Months Post-transplant

Timeframe: 6 months

Trial details

NCT IDNCT04194437

SponsorTransMedics

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2022-03-22

Results submitted2024-12-23

View on ClinicalTrials.gov More Liver Transplant trials